Long COVID After Bamlanivimab Treatment

By sjmartinez • August 31, 2023

Evering TH, Moser CB, Jilg N, Yeh E, Sanusi B, Wohl DA, Daar ES, Li JZ, Klekotka P, Javan AC, Eron JJ, Currier JS, Hughes MD, Smith DM, Chew KW; ACTIV-2/A5401 Study Team. Long COVID After Bamlanivimab Treatment. J Infect Dis. 2023 Aug 31;228(Supplement_2):S126-S135. doi: 10.1093/infdis/jiad286. PMID: 37650236.

Tags: bamlanivimab, Clinical Trial, Harbor UCLA, Infectious Diseases, long COVID, postacute sequelae of SARS-CoV-2 infection (PASC), Publications, symptom

Efficacy of an oral lipid nanocrystal formulation of amphotericin B (MAT2203) in the neutropenic mouse model of pulmonary mucormycosis

Gu Y, Gebremariam T, Alkhazraji S, Youssef E, El-Gamal S, Matkovits T, Cobb J, Mannino R, Ibrahim AS. Efficacy of an oral lipid nanocrystal formulation[...]

A Leaky False Pouch: Left Ventricle Pseudoaneurysm with Active Hemopericardium Detected on Cardiac Computed Tomography Angiography

Barforoshi S, Shekar C, Yu Z, Liu E, Manubolu V, Budoff MJ, Roy SK. A Leaky False Pouch: Left Ventricle Pseudoaneurysm with Active Hemopericardium Detected[...]

Comparing Cardiovascular Events Across Home Dialysis Modalities: Adjusting the Unadjustable?

Nadeau-Fredette AC, Shen JI, Perl J. Comparing Cardiovascular Events Across Home Dialysis Modalities: Adjusting the Unadjustable? Kidney360. 2024 Apr 1;5(4):489-491. doi: 10.34067/KID.0000000000000397. PMID: 38662536.